Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
William Hauswirth
University of Pennsylvania, Department: Veterinary Sciences
Should you be removed from our database? Contact us at [email protected]. Read more below.
Applied Genetic Technologies
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Hauswirth owns stock in and is a consultant for AGTC, a company which licenses from UF technology to make the AAV vector. The vector is used in the study and AGTC could be affected by the study. Dr. Hauswirth’s Significant Financial Interest could directly affect the design, conduct or reporting of the research.
Translational Gene Therapy for Rhodopsin Autosomal Dominant Retinitis Pigmentosa
RELEVANCE (See instructions): Past experience in successfully translating a gene therapy approach for LCA to human patients, and the available resources that this consortium of investigators brings, is a unique opportunity to now target RHO- ADRP. This is one of the most common forms of inherited retinal degeneration for which there is currently no specific treatment available.
Filed on March 05, 2013.
Tell us what you know about William Hauswirth's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “William Hauswirth”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| William Hauswirth | University of Pennsylvania | Conflict of Interest | Applied Genetic Technologies Corp. | $20,000 - $39,999 |
| William Hauswirth | University of Pennsylvania | Conflict of Interest | Applied Genetic Technologies | $40,000 - $59,999 |
| William Hauswirth | University of Florida | Conflict of Interest | Applied Genetic Technologies C | $40,000 - $59,999 |
| William Hauswirth | University of Florida | Conflict of Interest | Applied Genetic Technologies C | $20,000 - $39,999 |
| William Hauswirth | University of Pennsylvania | Conflict of Interest | Applied Genetic Technologies Corp. | $100,000 - $149,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.